Retirement Planning Co of New England Inc. Decreases Stock Position in GE HealthCare Technologies Inc. $GEHC

Retirement Planning Co of New England Inc. lessened its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 8.3% in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 3,486 shares of the company’s stock after selling 317 shares during the period. Retirement Planning Co of New England Inc.’s holdings in GE HealthCare Technologies were worth $281,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also recently made changes to their positions in GEHC. Knuff & Co LLC lifted its position in shares of GE HealthCare Technologies by 1.5% in the first quarter. Knuff & Co LLC now owns 10,276 shares of the company’s stock worth $829,000 after buying an additional 150 shares in the last quarter. Graypoint LLC increased its stake in GE HealthCare Technologies by 5.7% in the 1st quarter. Graypoint LLC now owns 3,028 shares of the company’s stock worth $244,000 after acquiring an additional 162 shares during the last quarter. Ferguson Wellman Capital Management Inc. raised its holdings in shares of GE HealthCare Technologies by 3.2% during the 1st quarter. Ferguson Wellman Capital Management Inc. now owns 5,336 shares of the company’s stock worth $431,000 after acquiring an additional 166 shares in the last quarter. Spire Wealth Management boosted its position in shares of GE HealthCare Technologies by 5.2% during the 1st quarter. Spire Wealth Management now owns 3,367 shares of the company’s stock valued at $272,000 after acquiring an additional 166 shares during the last quarter. Finally, Freestone Capital Holdings LLC grew its holdings in shares of GE HealthCare Technologies by 5.1% in the first quarter. Freestone Capital Holdings LLC now owns 3,454 shares of the company’s stock valued at $279,000 after purchasing an additional 169 shares in the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Up 0.0%

Shares of GEHC opened at $73.73 on Monday. The company’s fifty day simple moving average is $74.23 and its 200-day simple moving average is $74.55. The company has a market cap of $33.66 billion, a P/E ratio of 15.11, a P/E/G ratio of 2.82 and a beta of 1.13. The company has a current ratio of 1.16, a quick ratio of 0.93 and a debt-to-equity ratio of 0.85. GE HealthCare Technologies Inc. has a twelve month low of $57.65 and a twelve month high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings results on Wednesday, July 30th. The company reported $1.06 EPS for the quarter, topping analysts’ consensus estimates of $0.91 by $0.15. GE HealthCare Technologies had a net margin of 11.22% and a return on equity of 23.93%. The firm had revenue of $5 billion during the quarter, compared to analysts’ expectations of $4.96 billion. During the same period in the previous year, the company earned $1.00 EPS. The firm’s revenue for the quarter was up 3.5% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. As a group, analysts expect that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Friday, July 25th were paid a dividend of $0.035 per share. The ex-dividend date of this dividend was Friday, July 25th. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio is currently 2.87%.

Analysts Set New Price Targets

A number of research firms recently issued reports on GEHC. Morgan Stanley decreased their price target on shares of GE HealthCare Technologies from $78.00 to $74.00 and set an “equal weight” rating on the stock in a research note on Thursday, July 31st. Wall Street Zen upgraded shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating in a report on Saturday, May 31st. BTIG Research restated a “buy” rating on shares of GE HealthCare Technologies in a research report on Monday, July 14th. UBS Group upgraded GE HealthCare Technologies from a “sell” rating to a “neutral” rating and dropped their price target for the stock from $74.00 to $73.00 in a research report on Monday, May 5th. Finally, Citigroup boosted their price objective on GE HealthCare Technologies from $89.00 to $93.00 and gave the stock a “buy” rating in a research note on Thursday, July 31st. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $88.55.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.